Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZNGA
1001
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $41.6M | 0.01% |
5,530,270
+260,148
| +5% | +$2.36M |
|
|
NVTA
1002
DELISTED
Invitae Corporation
NVTA
| $41.6M | 0.01% |
1,464,400
+102,918
| +8% | +$3.02M |
|
1003
TriNet
TNET
$3.02B
| $41.6M | 0.01% |
440,123
-15,493
| -3% | -$1.33M |
|
|
IAA
1004
DELISTED
IAA, Inc. Common Stock
IAA
| $41.6M | 0.01% |
762,513
+25,871
| +4% | +$1.43M |
|
1005
QuidelOrtho
QDEL
$997M
| $41.5M | 0.01% |
294,192
+83,600
| +40% | +$11.2M |
|
1006
Q2 Holdings
QTWO
$3.84B
| $41.5M | 0.01% |
517,802
+15,867
| +3% | +$1.45M |
|
1007
Jazz Pharmaceuticals
JAZZ
$16.2B
| $41.5M | 0.01% |
318,558
-4,558
| -1% | -$689K |
|
1008
B&G Foods
BGS
$292M
| $41.5M | 0.01% |
1,386,823
+105,930
| +8% | +$3.18M |
|
1009
Armstrong World Industries
AWI
$7.77B
| $41.3M | 0.01% |
432,779
+12,193
| +3% | +$1.28M |
|
1010
Iridium Communications
IRDM
$5.26B
| $41.1M | 0.01% |
1,031,820
+90,064
| +10% | +$3.78M |
|
|
GAP
1011
The Gap Inc
GAP
$7.26B
| $41.1M | 0.01% |
1,809,741
+16,481
| +0.9% | +$455K |
|
1012
Ashland
ASH
$3.4B
| $41M | 0.01% |
460,530
+170,433
| +59% | +$15M |
|
|
CHX
1013
DELISTED
ChampionX
CHX
| $41M | 0.01% |
1,835,389
+54,111
| +3% | +$1.24M |
|
1014
Bankunited
BKU
$3.39B
| $40.9M | 0.01% |
978,968
+48,491
| +5% | +$1.98M |
|
1015
Lincoln Electric
LECO
$15.5B
| $40.9M | 0.01% |
317,265
+7,828
| +3% | +$1.06M |
|
1016
MasTec
MTZ
$22.8B
| $40.9M | 0.01% |
473,523
+12,955
| +3% | +$1.23M |
|
1017
Simpson Manufacturing
SSD
$7.97B
| $40.8M | 0.01% |
381,377
+10,302
| +3% | +$1.14M |
|
1018
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $40.8M | 0.01% |
774,995
-19,885
| -3% | -$1.07M |
|
|
SEM
1019
DELISTED
Select Medical
SEM
| $40.7M | 0.01% |
2,090,324
+35,212
| +2% | +$699K |
|
|
CDK
1020
DELISTED
CDK Global, Inc.
CDK
| $40.7M | 0.01% |
956,197
+317,357
| +50% | +$14.3M |
|
1021
Watts Water Technologies
WTS
$13B
| $40.6M | 0.01% |
241,825
+2,057
| +0.9% | +$330K |
|
1022
Curtiss-Wright
CW
$26.8B
| $40.6M | 0.01% |
322,018
-6,644
| -2% | -$794K |
|
1023
AptarGroup
ATR
$8.49B
| $40.6M | 0.01% |
339,870
+12,016
| +4% | +$1.58M |
|
1024
Universal Display
OLED
$4.25B
| $40.5M | 0.01% |
237,159
+13,875
| +6% | +$2.87M |
|
1025
Herbalife
HLF
$1.23B
| $40.4M | 0.01% |
954,433
+357,611
| +60% | +$17.7M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.